A detailed history of North Star Investment Management Corp. transactions in Purple Biotech Ltd. stock. As of the latest transaction made, North Star Investment Management Corp. holds 300 shares of PPBT stock, worth $111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$111
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 12, 2021

BUY
$3.81 - $4.73 $1,143 - $1,419
300 New
300 $1,000

Others Institutions Holding PPBT

About PURPLE BIOTECH LTD.


  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $6.77M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.